Vivos (RDGL) Selling, General & Administrative (2010 - 2025)
Vivos (RDGL) Selling, General & Administrative (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 90,535.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90,535.00 |
| Sep 30, 2025 | 72,904.00 |
| Jun 30, 2025 | 80,913.00 |
| Mar 31, 2025 | 52,203.00 |
| Dec 31, 2024 | 98,356.00 |
| Sep 30, 2024 | 65,123.00 |
| Jun 30, 2024 | 54,925.00 |
| Mar 31, 2024 | 23,420.00 |
| Dec 31, 2023 | 32,942.00 |
| Sep 30, 2023 | 31,357.00 |
| Jun 30, 2023 | 57,792.00 |
| Mar 31, 2023 | 43,683.00 |
| Dec 31, 2022 | 39,759.00 |
| Sep 30, 2022 | 38,302.00 |
| Jun 30, 2022 | 34,949.00 |
| Mar 31, 2022 | 37,100.00 |
| Dec 31, 2021 | 29,402.00 |
| Sep 30, 2021 | 22,131.00 |
| Jun 30, 2021 | 30,330.00 |
| Mar 31, 2021 | 35,835.00 |